| Previous Close | 0.504 |
| Open | 0.543 |
| Volume | 121,802 |
| Avg. Volume (3M) | 3,620,192 |
| Market Cap | 4,193,014 |
| Price / Earnings (TTM) | 0.922 |
| Price / Earnings (Forward) | 714.29 |
| Price / Sales | 0.050 |
| Price / Book | 0.740 |
| 52 Weeks Range | |
| Earnings Date | 12 Aug 2025 - 18 Aug 2025 |
| Profit Margin | -0.81% |
| Operating Margin (TTM) | -10.23% |
| Diluted EPS (TTM) | 86.16 |
| Quarterly Revenue Growth (YOY) | 8.50% |
| Total Debt/Equity (MRQ) | 171.99% |
| Current Ratio (MRQ) | 0.630 |
| Levered Free Cash Flow (TTM) | 4.88 M |
| Return on Assets (TTM) | -6.23% |
| Return on Equity (TTM) | -8.46% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Drug Manufacturers - Specialty & Generic (US) | Bullish | Mixed |
| Drug Manufacturers - Specialty & Generic (Global) | Bullish | Mixed | |
| Stock | cbdMD, Inc. | - | - |
AIStockmoo Score
| Analyst Consensus | 2.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -2.5 |
| Average | 0.63 |
|
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. The company also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name. It distributes its products through its e-commerce website, third-party e-commerce sites, wholesalers, and various brick and mortar retailers in the United States. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was incorporated in 2015 and is headquartered in Charlotte, North Carolina. |
|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| % Held by Insiders | 16.10% |
| % Held by Institutions | 3.00% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Chapin Davis, Inc. | 30 Sep 2025 | 121,551 |
| Alesco Advisors Llc | 30 Sep 2025 | 68,513 |
| Commonwealth Equity Services, Llc | 30 Sep 2025 | 16,255 |
| Sassicaia Capital Advisers Llc | 30 Sep 2025 | 12,000 |
| Harbour Investments, Inc. | 30 Sep 2025 | 5,200 |
| Golden State Wealth Management, Llc | 30 Sep 2025 | 4 |
| Date | Type | Details |
|---|---|---|
| 21 Nov 2025 | Announcement | cbdMD Reports Preliminary Unaudited Fourth Quarter and Fiscal 2025 Results |
| 22 Oct 2025 | Announcement | cbdMD's Herbal Oasis Hemp-Derived THC-Infused Social Seltzer Brand Expands its Product Offerings |
| 09 Oct 2025 | Announcement | cbdMD's Herbal Oasis Expands its Florida Footprint with Bevtalk Distribution Partnership |
| 01 Oct 2025 | Announcement | cbdMD, Inc. Announces Closing of $1.7 Million Series B Preferred Private Placement |
| 25 Sep 2025 | Announcement | cbdMD Announces Inferno Freeze: Our Most Powerful Topical |
| 24 Sep 2025 | Announcement | Herbal Oasis Expands Beyond the Southeast, Launches in Minnesota with Global Reserve Distribution |
| 16 Sep 2025 | Announcement | Herbal Oasis Expands into Tennessee with Best Brands |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |